Nusano
  • Company
    • Leadership
    • Medical Iso Advisory Board
    • Strategic Advisory Board
    • Mission & Values
  • Technology
  • Energy
    • HALEU
    • Nuclear Fuel Cycle
    • Nuclear Batteries
  • Industrial
  • Life Sci
    • Medical Isotopes
    • Request Quote
    • R&D Collaboration
    • About Nuclear Med
  • Minerals
  • News
    • Press Releases
    • Nu-Blog
    • Video
    • Podcast
    • Email Sign Up
  • Careers
    • Current Openings
    • West Valley City
    • Life in Utah
  • Contact
Select Page
dGenThera and Nusano Sign Letter of Intent for Astatine‑211 Supply

dGenThera and Nusano Sign Letter of Intent for Astatine‑211 Supply

by Scott Larrivee | Jun 19, 2025 | News

Alpha-emitting radioisotope expected to play an essential role in next-generation targeted cancer therapies  DURHAM, N.C. and WEST VALLEY CITY, Utah – June 19, 2025 – dGenThera, Inc., a biotechnology company pioneering theranostic molecular pairs, and Nusano, a...

Recent Posts

  • Anson Provides High-Concentration Lithium Chloride Sample to Nusano for Test Work
  • Talk Radioisotopes: 2025 Top Podcasts #1
  • Talk Radioisotopes: 2025 Top Podcasts #2
  • Talk Radioisotopes: 2025 Top Podcasts #3
  • 2025 Recap: A Look Back at How We Are Moving Forward

Recent Comments

No comments to show.
Nusano
Supplying the fight against cancer & enabling life-changing innovations
  • Follow
  • Follow
  • Follow
  • Follow
Company
about us
Leadership
Contact us
technology

The Nusano Platform
R&D Collaboration

Resources
News
Careers
Suppliers
© 2026 Nusano | Web design
Privacy Policy – Terms of Service